Quest Diagnostics Incorporated (DGX)
Quest Diagnostics Incorporated is listed on NYSE (DGX) in the Healthcare sector. Prices from Yahoo Finance with their delay; analysis computed from daily price history.
All stocks — US stocks · Heatmap
- Exchange
- NYSE · Closed Opens in 22h 01m
- Data delay
- 20 min
- Day range
- 250.02 – 258.13
- Prev. close
- 254.74
Key statistics
- Open
- 251.64
- Previous close
- 254.74
- 52-week range
- 171.18 – 259.00
- Volume
- 945.2K
- Avg volume (3M)
- 1M
- Market cap
- 28.2B USD
- P/E (TTM)
- 25.5
- EPS (TTM)
- 10.04
- Dividend yield
- 1.35%
- Sector
- Healthcare Diagnostics & Research
- Listed in
- S&P 500
- Currency
- USD
Chart
Movement expectation (statistical)
Ranges the price would stay in with a given probability if its recent volatility continues.
| Horizon | ≈68% range (±1σ) | ≈95% range (±2σ) | Past fit |
|---|---|---|---|
| Next trading day | 252.07 – 259.24 ±1.41% | 248.55 – 262.91 | 72% / 94% of the last 250 periods stayed inside |
| Next 5 trading days | 247.73 – 263.78 ±3.19% | 240.08 – 272.19 | 67% / 92% of the last 251 periods stayed inside |
ATR range (Next trading day): 248.91 – 262.35 · (Next 5 trading days): 240.61 – 270.65
Daily volatility (σ, 60 days): 1.40%. Basis: close of 2026-11-06 and current price.
⚠️ These are statistical ranges calculated from the stock's own past volatility. They are not a price target, a forecast or a recommendation to buy or sell. Prices can and do move outside them, especially around earnings and news.
Trend reading
Uptrend A description of the indicators, not a recommendation.
- Price is above its 200-day average: the long-term trend is up.
- The 50-day average is above the 200-day (golden-cross structure).
- Short term: above both the 20- and 50-day averages.
- RSI 66.9: neutral zone (30–70).
- MACD is above its signal line (positive momentum).
- At or near the 52-week high.
Pivot points
| Classic | Fibonacci | |
|---|---|---|
| R3 | 267.30 | 262.72 |
| R2 | 262.72 | 259.61 |
| R1 | 259.17 | 257.69 |
| P | 254.59 | 254.59 |
| S1 | 251.04 | 251.48 |
| S2 | 246.46 | 249.56 |
| S3 | 242.91 | 246.46 |
From the 2026-11-06 daily bar (H 258.13 · L 250.00 · C 255.63)
Moving averages
| Moving averages | Price | MA signal |
|---|---|---|
| SMA20 | 244.48 | Above |
| SMA50 | 239.63 | Above |
| SMA200 | 214.16 | Above |
| EMA20 | 246.61 | Above |
| EMA50 | 240.14 | Above |
MA signal: Strong buy · RSI (14): 66.9 · 1M volatility (ann.): 21.6%
Performance
MACD (12, 26, 9)
- MACD
- 5.167
- Signal
- 3.913
- Histogram
- 1.254
- ATR (14)
- 6.72
Position in the sector heatmap
Today #28 of 61 Healthcare stocks in US by change; sector average -0.05%.
Sector peers
Largest Healthcare stocks in US by market cap
| Eli Lilly and CompanyLLY | 1,354.00 USD | -0.79% | 3.6M | 1.21T USD | Healthcare |
|---|---|---|---|---|---|
| Johnson & JohnsonJNJ | 276.22 USD | +1.43% | 8.9M | 664.9B USD | Healthcare |
| AbbVie Inc.ABBV | 291.31 USD | +1.07% | 5M | 514.9B USD | Healthcare |
| Merck & Co., Inc.MRK | 146.73 USD | -0.14% | 7.5M | 361.7B USD | Healthcare |
| UnitedHealth Group IncorporatedUNH | 394.15 USD | -0.40% | 5.8M | 353.2B USD | Healthcare |
| Thermo Fisher Scientific Inc.TMO | 694.76 USD | +2.63% | 2.1M | 257.4B USD | Healthcare |
| Amgen Inc.AMGN | 460.42 USD | +0.03% | 2.6M | 249B USD | Healthcare |
| Gilead Sciences, Inc.GILD | 166.89 USD | -0.41% | 5.7M | 207B USD | Healthcare |
| Abbott LaboratoriesABT | 109.93 USD | -3.23% | 8.2M | 190.4B USD | Healthcare |
| Pfizer Inc.PFE | 29.39 USD | -0.20% | 48.2M | 167.5B USD | Healthcare |
| Danaher CorporationDHR | 230.25 USD | +1.73% | 3.7M | 162B USD | Healthcare |
| Intuitive Surgical, Inc.ISRG | 452.80 USD | -3.36% | 2.1M | 157B USD | Healthcare |
| Quest Diagnostics IncorporatedDGX | 255.63 USD | +0.35% | 945.2K | 28.2B USD | Healthcare |
Delays: NYSE 20 min · Nasdaq 15 min